Cannabis Connections Symposium: Bringing Consumers, Medical Communities, and the Industry Together
Join CCI for an intimate and exclusive event of presentations and conversations with industry leaders bringing a fresh perspective to cannabis. *Limited Space Available
When: Wednesday, June 5, 2019
Time: 8:00am – 5:00pm
Where: CU Boulder - University Memorial Center; UMC 235 Multipurpose; Boulder, CO 80309
Reception: Immediately following symposium 5:30–7:30pm at The Rio Grande: 1101 Walnut St, Boulder, CO 80302
8:00am – 8:30am REGISTRATION
8:45am – 9:30am Cannabis and Veterinary Medicine, Stephen Cital, RVT, RLAT, SRA, VCCS, VTS- LAM
9:30am – 10:15am Ditching the Joint: How Formulated Cannabis Products will Make Cannabis Mainstream,Tristan Watkins, PhD, CSO LucidMood
10:15am – 11:00am Cannabis Chemistry and Pharmacology: Towards Customized Formulations for Health and Wellness, Brian G. Reid, PhD, Head of Scientific Research, Americas, Canopy Growth USA
11:00am – 11:45am Kelsey's Update, Kelsey Darragh, highly influential medial cannabis patient gives her update
11:45am – 12:30pm Medical Cannabis: Weed or Wonder Drug? Dr. David Casarett, Chief of Palliative Care, Professor of Medicine, Duke University/Duke Health (as seen on TEDMED)
12:30pm – 1:15pm LUNCH (included)
1:15pm – 2:00pm Cannabis Regulations Defined: Keeping up with Current Events and Taking Proactive Action,Karli Thomas, Regulatory Compliance Advisor for Cosmetics, Nutraceuticals, Cannabis, and Consumer Goods
2:00pm – 2:45pm The Future of Cosmetics, Terpenes, and Cannabis, Alexis Mayne, Chief Operations Officer, Sanitas Skincare/Rocky Mountain Natural Labs.
2:45pm – 3:30pm Combat to Cannabis: Science Behind the Story, Dan Schmink, US Army Combat Veteran CEO, Deviant Apex
3:30pm – 4:15pm Athletes for Care, Athlete Ambassador, Nate Jackson –former NFL Tight end, joined by former Bronco players
4:15pm – 4:45pm Interactive Panel Q&A – with Moderator
5pm Closing Remarks / Conclusion
5:30pm – 7:30pm Reception - The Rio Grande, Boulder
PANEL OF SPEAKERS
Diverse perspectives on cannabis research, innovation, brands, and patient success.
Stephen Cital, RVT, RLAT, SRA, VCCS, VTS- LAM, Veterinary Cannabis Counselor Specialist, Veterinary Cannabis Academy-Co-Founder
Cannabis in Veterinary Medicine
Stephen is Executive Director for the Academy of Laboratory Animal Veterinary Technicians and Nurses, holding a Veterinary Technician Specialist (VTS) credential in Research Anesthesia. Stephen is also Veterinary Cannabis Counselor Specialists, one of only a handful in the country. This lecture will discuss our current understating of cannabis products in veterinary species by reviewing the current literature and ongoing studies. We will review current uses of cannabis products in animals and veterinary specific concerns with product development. We will also briefly discuss the legal concerns veterinary practitioners are facing.
Tristan Watkins, PhD in Neuroscience, Chief Science Officer of LucidMood.
Ditching the joint: How Formulated Cannabis Products will Make Cannabis Mainstream
Dr. Tristan Watkins is a neuroscientist that studies how terpenes and cannabinoids interact with the nervous system and applies this knowledge to creating cannabis formulas that deliver distinct and consistent effects. His cannabis research began as a passion project during graduate school at Vanderbilt University, where he researched reward system activation in cannabis users and how changes in brain structure and function lead to changes in cognition and behavior - publishing six papers in the process. Dr. Watkins currently serves as the Chief Scientific Officer of LucidMood, the leading brand of functional cannabis products.
Brian G. Reid, PhD, Head of Scientific Research, Americas, Canopy Growth USA (formerly the CSO of Ebbu –acquired by Canopy Growth Nov. 2018).
Cannabis Chemistry and Pharmacology: Towards Customized Formulations for Health and Wellness
Dr. Reid leads a multifunctional Research & Development team of scientists working to craft next generation cannabis products. Dr. Reid's approach focuses on analytical chemistry, preparative scale chromatography, cellular pharmacology, formulation science and volunteer-based observational studies.
Kelsey Darragh, highly influential medical cannabis patient
Kelsey Darragh, a comedian, director, and producer who has made hundreds of videos for BuzzFeed amassing over 1 billion views. When she was diagnosed with Trigeminal Neuralgia after a botched TMJ surgery in 2015, she started making videos about chronic pain and invisible illness. Last year, Kelsey made a video titled "I tried Medical Marijuana For My Chronic Pain" that went viral. With over 4 million views in a day, the cannabis industry started to use her video as a marketing tool to reach audiences that weren't previously aware of the benefits of using medical marijuana over opioids. A year later, Kelsey gives us an update on her journey navigating the seemingly hopeless community of people living with chronic pain and how she's watched medical marijuana change people’s lives.
David Casarett, MD MA has over 2million views from his 2016 TEDMED: "A doctor's case for medical marijuana."
Dr. Casarett is a palliative care physician and health services researcher whose major research interest is understanding and improving the way that health systems care for patients near the end of life. His work has included studies of hospice and hospice alternatives, as well as a randomized controlled trial of a decision aid to improve end of life care.
Dr. Casarett’s research has been supported by the VA, NIH, AHRQ, the American Cancer Society, the Paul Beeson Physician Scholars Program, and by grants from the Hartford Foundation, the Aetna Foundation, the Commonwealth Fund, and the Greenwall Foundation.
Medical Cannabis: Weed or wonder drug?
He is a professor of Medicine at Duke University and the Chief of Palliative Care for Duke Health where he directs the Duke Center for Palliative Care. He is a recipient of the Presidential Early Career Award for Scientists and Engineers, the highest honor given by the US government to researchers in the early stages of their careers.
Dr. Casarett is the author of more than 140 articles in journals including JAMA and The New England Journal of Medicine. His writing has appeared in print and online in Salon, Esquire, Discover, Newsweek, the New York Times, and Wired. Dr. Casarett is also the author of three non-fiction books, the most recent of which was Stoned: A Doctor’s Case for Medical Marijuana, published in 2015 by Penguin Random House.
Karli Thomas, Regulatory Affairs Advisor – Pharmaceuticals, Cosmetics, and Cannabis
Cannabis Regulations Defined: Keeping up with Current Events and Taking Proactive Action.
Karli Thomas is experienced in regulatory affairs and compliance with over a decade of global experience within internal regulatory roles. She has served as an independent consultant, while defining regulatory requirements by creating project roadmaps to obtain goals alongside favorable outcomes. She is driven by principles and ethics to advise and ensure people, organizations, and companies achieve success without compromising their quality, integrity or compliance.
Today, she is focused on projects including: thoroughly defining CMC requirements, drug registration, and extensive cannabis research. Being a responsible and proactive regulatory professional is essential to protect the industry with reliable and truthful information, in addition to improving individual lives and society by supporting and promoting health and well-being based on substantiated scientific information.
Alexis Mayne, VP of Research & Development, COO of Sanitas Skincare and Rocky Mountain Natural Labs
The Future of Cosmetics, Terpenes, and Cannabis
Alexis has spent 20 years in the personal care and cosmetics industries and she is passionate about integrating new product development with exceptional production quality, international regulations-compliance and market integration. Her expertise in product formulation and development is integrated with her knack for unique market segments and successful product growth. She has worked with a variety of companies and brands in developing on-trend products for their unique markets from Elizabeth Arden’s legacy brand to the Sandals and Beaches resorts.
In addition to spearheading new product and product line development, Alexis implemented quality and compliance systems; writing and implementing SOP’s and achieving cGMP certification and ISO22716 compliance. In addition to ensuring product safety and integrity testing she has taken multiple products through the European Safety Assessment process in order to bring them to international markets.
Dan Schmink, CEO, Deviant Apex, US Army Combat Veteran
Combat to Cannabis: Science Behind the Story
Dan is a US Army combat veteran that has led the national discussion for many years regarding veterans suffering from PTSD after military combat. His journey towards PTSD recovery, cannabis insights, and experience working with researchers and other veterans brings a unique perspective for translating statistics into a story worth sharing.
Nate Jackson, Athlete Ambassador for Athletes for Care
Professional Athletes and Cannabis
Nate Jackson, Former NFL Tight End for San Francisco 49ers, Denver Broncos, Cleveland Browns, Athlete Ambassador, Athletes for Care. Nate Jackson is a New York Times Bestselling author and freelance writer for a variety of popular websites and newspapers. His latest book Fantasy Man was released in September 2016.
Cannabis Connections Symposium: Bringing Consumers, Medical Communities, and the Industry Together
Join CCI for an intimate and exclusive event of presentations and conversations with industry leaders bringing a fresh perspective to cannabis. *Limited seats available